Shamburg News · 8-K filed Nov 12, 2026, 4:05 PM EST
Journey Medical Reports Third Quarter 2026 Revenue of $19.0 Million and Net Loss of $1.3 Million
DERM · Journey Medical Corp
- Earnings
- Financial statements
- Materiality: high
Journey Medical Corporation reported third quarter 2026 total revenues of $19.0 million, an 8% increase from $17.6 million a year earlier, with Emrosi revenues of $9.0 million. The company reported a GAAP net loss of $1.3 million, or $(0.05) per share basic and diluted, compared with a net loss of $2.3 million, or $(0.09) per share, in the prior-year quarter. Cash and cash equivalents were $22.3 million at September 30, 2026, and the company reported positive EBITDA and Adjusted EBITDA for the three- and nine-month periods.
Source: SEC EDGAR, Form 8-K, Items 2.02, 9.01, accession 0001104659-26-126209.
Written from the filing by Shamburg Markets. Figures are as reported by the company.